Regulating the 20S proteasome ubiquitin-independent degradation pathway

Biomolecules

Volumn 4, Issue 3, 2014, Pages 862-884

  Ben Nissan, Gili ^a   Sharon, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

20s proteasome; Intrinsically disordered proteins; Oxidatively damaged proteins; Protein degradation; Regulatory mechanisms

Indexed keywords

PROTEASOME; REGULATOR PROTEIN; UBIQUITIN; ATP DEPENDENT 26S PROTEASE;

CELL METABOLISM; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REGULATION; GENE CONTROL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SUBUNIT; REVIEW; TRANSLATIONAL PROTEIN MODIFICATION; ANIMAL; METABOLISM;

ANIMALS; HUMANS; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; UBIQUITIN;

EID: 84924735979     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom4030862     Document Type: Review

References (142)

1. Powers, E.T.; Morimoto, R.I.; Dillin, A.; Kelly, J.W.; Balch, W.E. Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 2009, 78, 959-991.
2. Eden, E.; Geva-Zatorsky, N.; Issaeva, I.; Cohen, A.; Dekel, E.; Danon, T.; Cohen, L.; Mayo, A.; Alon, U. Proteome half-life dynamics in living human cells. Science 2011, 331, 764-768.
3. Schmidt, M.; Finley, D. Regulation of proteasome activity in health and disease. Biochim. Biophys. Acta 2014, 1843, 13-25.
4. Goldberg, A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 2003, 426, 895-899.
5. Schwartz, A.L.; Ciechanover, A. Targeting proteins for destruction by the ubiquitin system: Implications for human pathobiology. Annu. Rev. Pharmacol. Toxicol. 2009, 49, 73-96.
6. Kish-Trier, E.; Hill, C.P. Structural biology of the proteasome. Annu. Rev. Biophys. 2013, 42, 29-49.
7. Hwang, J.; Winkler, L.; Kalejta, R.F. Ubiquitin-independent proteasomal degradation during oncogenic viral infections. Biochim. Biophys. Acta 2011, 1816, 147-157.
8. Pickering, A.M.; Davies, K.J. Degradation of damaged proteins: The main function of the 20S proteasome. Prog. Mol. Biol. Transl. Sci. 2012, 109, 227-248.
9. Erales, J.; Coffino, P. Ubiquitin-independent proteasomal degradation. Biochim. Biophys. Acta 2014, 1843, 216-221.
10. Asher, G.; Tsvetkov, P.; Kahana, C.; Shaul, Y. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 2005, 19, 316-321.
11. Aiken, C.T.; Kaake, R.M.; Wang, X.; Huang, L. Oxidative stress-mediated regulation of proteasome complexes. Mol. Cell. Proteomics 2011, doi: 10.1074/mcp.M110.006924.
12. Van der Lee, R.; Buljan, M.; Lang, B.; Weatheritt, R.J.; Daughdrill, G.W.; Dunker, A.K.; Fuxreiter, M.; Gough, J.; Gsponer, J.; Jones, D.T.; et al. Classification of intrinsically disordered regions and proteins. Chem. Rev. 2014, 114, 6589-6631.
13. Dyson, H.J.; Wright, P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 2005, 6, 197-208.
14. Li, X.; Amazit, L.; Long, W.; Lonard, D.M.; Monaco, J.J.; O’Malley, B.W. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the reggamma-proteasome pathway. Mol. Cell 2007, 26, 831-842.
15. Sheaff, R.J.; Singer, J.D.; Swanger, J.; Smitherman, M.; Roberts, J.M.; Clurman, B.E. Proteasomal turnover of p21CIP1 does not require p21CIP1 ubiquitination. Mol. Cell 2000, 5, 403-410.
16. Tambyrajah, W.S.; Bowler, L.D.; Medina-Palazon, C.; Sinclair, A.J. Cell cycle-dependent caspase-like activity that cleaves p27(KIP1) is the beta(1) subunit of the 20S proteasome. Arch. Biochem. Biophys. 2007, 466, 186-193.
17. Garate, M.; Wong, R.P.; Campos, E.I.; Wang, Y.; Li, G. NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b). EMBO Rep. 2008, 9, 576-581.
18. Rokah, O.H.; Shpilberg, O.; Granot, G. NAD(P)H quinone oxidoreductase protects TAp63gamma from proteasomal degradation and regulates TAp63gamma-dependent growth arrest. PLoS One 2010, 5, e11401.
19. Patrick, B.A.; Gong, X.; Jaiswal, A.K. Disruption of NAD(P)H: Quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer. Oncogene 2011, 30, 1098-1107.
20. Kalejta, R.F.; Shenk, T. Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc. Natl. Acad. Sci. USA 2003, 100, 3263-3268.
21. Wiggins, C.M.; Tsvetkov, P.; Johnson, M.; Joyce, C.L.; Lamb, C.A.; Bryant, N.J.; Komander, D.; Shaul, Y.; Cook, S.J. BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. J. Cell Sci. 2011, 124, 969-977.
22. Stewart, D.P.; Koss, B.; Bathina, M.; Perciavalle, R.M.; Bisanz, K.; Opferman, J.T. Ubiquitin-independent degradation of antiapoptotic MCL-1. Mol. Cell. Biol. 2010, 30, 3099-3110.
23. Adler, J.; Reuven, N.; Kahana, C.; Shaul, Y. c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H: Quinone oxidoreductase 1 determines c-Fos serum response kinetics. Mol. Cell. Biol. 2010, 30, 3767-3778.
24. Alvarez-Castelao, B.; Castano, J.G. Mechanism of direct degradation of Ikappabalpha by 20S proteasome. FEBS Lett. 2005, 579, 4797-4802.
25. Asher, G.; Bercovich, Z.; Tsvetkov, P.; Shaul, Y.; Kahana, C. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol. Cell 2005, 17, 645-655.
26. Kong, X.; Alvarez-Castelao, B.; Lin, Z.; Castano, J.G.; Caro, J. Constitutive/hypoxic degradation of HIF-alpha proteins by the proteasome is independent of von hippel lindau protein ubiquitylation and the transactivation activity of the protein. J. Biol. Chem. 2007, 282, 15498-15505.
27. Xu, J.; Jaiswal, A.K. NAD(P)H: Quinone oxidoreductase 1 (NQO1) competes with 20S proteasome for binding with C/EBPalpha leading to its stabilization and protection against radiation-induced myeloproliferative disease. J. Biol. Chem. 2012, 287, 41608-41618.
28. Adamovich, Y.; Shlomai, A.; Tsvetkov, P.; Umansky, K.B.; Reuven, N.; Estall, J.L.; Spiegelman, B.M.; Shaul, Y. The protein level of PGC-1alpha, a key metabolic regulator, is controlled by NADH-NQO1. Mol. Cell. Biol. 2013, 33, 2603-2613.
29. David, D.C.; Layfield, R.; Serpell, L.; Narain, Y.; Goedert, M.; Spillantini, M.G. Proteasomal degradation of tau protein. J. Neurochem. 2002, 83, 176-185.
30. Cardozo, C.; Michaud, C. Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a nonprocessive pathway. Arch. Biochem. Biophys. 2002, 408, 103-110.
31. Tofaris, G.K.; Layfield, R.; Spillantini, M.G. Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 2001, 509, 22-26.
32. Prilusky, J.; Felder, C.E.; Zeev-Ben-Mordehai, T.; Rydberg, E.H.; Man, O.; Beckmann, J.S.; Silman, I.; Sussman, J.L. Foldindex: A simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 2005, 21, 3435-3438.
33. Jariel-Encontre, I.; Bossis, G.; Piechaczyk, M. Ubiquitin-independent degradation of proteins by the proteasome. Biochim. Biophys. Acta 2008, 1786, 153-177.
34. Fabre, B.; Lambour, T.; Delobel, J.; Amalric, F.; Monsarrat, B.; Burlet-Schiltz, O.; Bousquet-Dubouch, M.P. Subcellular distribution and dynamics of active proteasome complexes unraveled by a workflow combining in vivo complex cross-linking and quantitative proteomics. Mol. Cell. Proteomics 2012, 12, 687-699.
35. Babbitt, S.E.; Kiss, A.; Deffenbaugh, A.E.; Chang, Y.H.; Bailly, E.; Erdjument-Bromage, H.; Tempst, P.; Buranda, T.; Sklar, L.A.; Baumler, J.; et al. ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle. Cell 2005, 121, 553-565.
36. Tanahashi, N.; Murakami, Y.; Minami, Y.; Shimbara, N.; Hendil, K.B.; Tanaka, K. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J. Biol. Chem. 2000, 275, 14336-14345.
37. Brooks, P.; Fuertes, G.; Murray, R.Z.; Bose, S.; Knecht, E.; Rechsteiner, M.C.; Hendil, K.B.; Tanaka, K.; Dyson, J.; Rivett, J. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 2000, 346, 155-161.
38. Baugh, J.M.; Viktorova, E.G.; Pilipenko, E.V. Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J. Mol. Biol. 2009, 386, 814-827.
39. Hohn, T.J.; Grune, T. The proteasome and the degradation of oxidized proteins: Part III-redox regulation of the proteasomal system. Redox Biol. 2014, 2, 388-394.
40. Wang, X.; Yen, J.; Kaiser, P.; Huang, L. Regulation of the 26S proteasome complex during oxidative stress. Sci. Signal. 2010, 3, ra88.
41. Grune, T.; Catalgol, B.; Licht, A.; Ermak, G.; Pickering, A.M.; Ngo, J.K.; Davies, K.J. HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radic. Biol. Med. 2011, 51, 1355-1364.
42. Huang, Q.; Wang, H.; Perry, S.W.; Figueiredo-Pereira, M.E. Negative regulation of 26S proteasome stability via calpain-mediated cleavage of Rpn10 subunit upon mitochondrial dysfunction in neurons. J. Biol. Chem. 2013, 288, 12161-12174.
43. Pickering, A.M.; Davies, K.J. Differential roles of proteasome and immunoproteasome regulators Pa28alphabeta, Pa28gamma and Pa200 in the degradation of oxidized proteins. Arch. Biochem. Biophys. 2012, 523, 181-190.
44. Imai, J.; Maruya, M.; Yashiroda, H.; Yahara, I.; Tanaka, K. The molecular chaperone Hsp90 plays a role in the assembly and maintenance of the 26S proteasome. EMBO J. 2003, 22, 3557-3567.
45. Inai, Y.; Nishikimi, M. Increased degradation of oxidized proteins in yeast defective in 26S proteasome assembly. Arch. Biochem. Biophys. 2002, 404, 279-284.
46. Shringarpure, R.; Grune, T.; Mehlhase, J.; Davies, K.J. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J. Biol. Chem. 2003, 278, 311-318.
47. Tsvetkov, P.; Myers, N.; Eliav, R.; Adamovich, Y.; Hagai, T.; Adler, J.; Navon, A.; Shaul, Y. NADH binds and stabilizes the 26S proteasomes independent of ATP. J. Biol. Chem. 2014, 289, 11272-11281.
48. Ma, C.P.; Slaughter, C.A.; DeMartino, G.N. Identification, purification, and characterization of a protein activator (PA28) of the 20S proteasome (macropain). J. Biol. Chem. 1992, 267, 10515-10523.
49. Stadtmueller, B.M.; Hill, C.P. Proteasome activators. Mol. Cell 2011, 41, 8-19.
50. Sugiyama, M.; Sahashi, H.; Kurimoto, E.; Takata, S.; Yagi, H.; Kanai, K.; Sakata, E.; Minami, Y.; Tanaka, K.; Kato, K. Spatial arrangement and functional role of alpha subunits of proteasome activator PA28 in hetero-oligomeric form. Biochem. Biophys. Res. Commun. 2013, 432, 141-145.
51. Whitby, F.G.; Masters, E.I.; Kramer, L.; Knowlton, J.R.; Yao, Y.; Wang, C.C.; Hill, C.P. Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 2000, 408, 115-120.
52. Ortega, J.; Heymann, J.B.; Kajava, A.V.; Ustrell, V.; Rechsteiner, M.; Steven, A.C. The axial channel of the 20S proteasome opens upon binding of the PA200 activator. J. Mol. Biol. 2005, 346, 1221-1227.
53. Sijts, A.; Sun, Y.; Janek, K.; Kral, S.; Paschen, A.; Schadendorf, D.; Kloetzel, P.M. The role of the proteasome activator PA28 in MHC class I antigen processing. Mol. Immunol. 2002, 39, 165-169.
54. Chen, X.; Barton, L.F.; Chi, Y.; Clurman, B.E.; Roberts, J.M. Ubiquitin-independent degradation of cell-cycle inhibitors by the reggamma proteasome. Mol. Cell 2007, 26, 843-852.
55. Li, X.; Lonard, D.M.; Jung, S.Y.; Malovannaya, A.; Feng, Q.; Qin, J.; Tsai, S.Y.; Tsai, M.J.; O’Malley, B.W. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell 2006, 124, 381-392.
56. Hernebring, M.; Fredriksson, A.; Liljevald, M.; Cvijovic, M.; Norrman, K.; Wiseman, J.; Semb, H.; Nystrom, T. Removal of damaged proteins during ES cell fate specification requires the proteasome activator PA28. Sci. Rep. 2013, doi: 10.1038/srep01381.
57. Qian, M.X.; Pang, Y.; Liu, C.H.; Haratake, K.; Du, B.Y.; Ji, D.Y.; Wang, G.F.; Zhu, Q.Q.; Song, W.; Yu, Y.; et al. Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis. Cell 2013, 153, 1012-1024.
58. Tar, K.; Dange, T.; Yang, C.; Yao, Y.; Bulteau, A.L.; Salcedo, E.F.; Braigen, S.; Bouillaud, F.; Finley, D.; Schmidt, M. Proteasomes associated with the Blm10 activator protein antagonize mitochondrial fission through degradation of the fission protein Dnm1. J. Biol. Chem. 2014, 289, 12145-12156.
59. Cascio, P.; Call, M.; Petre, B.M.; Walz, T.; Goldberg, A.L. Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. EMBO J. 2002, 21, 2636-2645.
60. Li, J.; Horak, K.M.; Su, H.; Sanbe, A.; Robbins, J.; Wang, X. Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J. Clin. Investig. 2011, 121, 3689-3700.
61. Blickwedehl, J.; Agarwal, M.; Seong, C.; Pandita, R.K.; Melendy, T.; Sung, P.; Pandita, T.K.; Bangia, N. Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability. Proc. Natl. Acad. Sci. USA 2008, 105, 16165-16170.
62. Meiners, S.; Keller, I.E.; Semren, N.; Caniard, A. Regulation of the proteasome: Evaluating the lung proteasome as a new therapeutic target. Antioxid. Redox Signal. 2014, doi: 10.1089/ars.2013.5798.
63. Schmidt, M.; Haas, W.; Crosas, B.; Santamaria, P.G.; Gygi, S.P.; Walz, T.; Finley, D. The HEAT repeat protein Blm10 regulates the yeast proteasome by capping the core particle. Nat. Struct. Mol. Biol. 2005, 12, 294-303.
64. Pickering, A.M.; Linder, R.A.; Zhang, H.; Forman, H.J.; Davies, K.J. Nrf2-dependent induction of proteasome and Pa28alphabeta regulator are required for adaptation to oxidative stress. J. Biol. Chem. 2012, 287, 10021-10031.
65. Kwak, M.K.; Wakabayashi, N.; Itoh, K.; Motohashi, H.; Yamamoto, M.; Kensler, T.W. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 2003, 278, 8135-8145.
66. Kwak, M.K.; Wakabayashi, N.; Greenlaw, J.L.; Yamamoto, M.; Kensler, T.W. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol. Cell. Biol. 2003, 23, 8786-8794.
67. Kwak, M.K.; Cho, J.M.; Huang, B.; Shin, S.; Kensler, T.W. Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells. Free Radic. Biol. Med. 2007, 43, 809-817.
68. Lee, C.S.; Lee, C.; Hu, T.; Nguyen, J.M.; Zhang, J.; Martin, M.V.; Vawter, M.P.; Huang, E.J.; Chan, J.Y. Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration. Proc. Natl. Acad. Sci. USA 2011, 108, 8408-8413.
69. Radhakrishnan, S.K.; Lee, C.S.; Young, P.; Beskow, A.; Chan, J.Y.; Deshaies, R.J. Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol. Cell 2010, 38, 17-28.
70. Lee, C.S.; Ho, D.V.; Chan, J.Y. Nuclear factor-erythroid 2-related factor 1 regulates expression of proteasome genes in hepatocytes and protects against endoplasmic reticulum stress and steatosis in mice. FEBS J. 2013, 280, 3609-3620.
71. Tsuchiya, Y.; Taniguchi, H.; Ito, Y.; Morita, T.; Karim, M.R.; Ohtake, N.; Fukagai, K.; Ito, T.; Okamuro, S.; Iemura, S.; et al. The casein kinase 2-Nrf1 axis controls the clearance of ubiquitinated proteins by regulating proteasome gene expression. Mol. Cell Biol. 2013, 33, 3461-3472.
72. Chepelev, N.L.; Bennitz, J.D.; Huang, T.; McBride, S.; Willmore, W.G. The Nrf1 CNC-bZIP protein is regulated by the proteasome and activated by hypoxia. PLoS One 2011, 6, e29167.
73. Steffen, J.; Seeger, M.; Koch, A.; Kruger, E. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol. Cell 2010, 40, 147-158.
74. Ferrington, D.A.; Gregerson, D.S. Immunoproteasomes: Structure, function, and antigen presentation. Prog. Mol. Biol. Transl. Sci. 2012, 109, 75-112.
75. Ebstein, F.; Kloetzel, P.M.; Kruger, E.; Seifert, U. Emerging roles of immunoproteasomes beyond MHC class I antigen processing. Cell. Mol. Life Sci. 2012, 69, 2543-2558.
76. Kniepert, A.; Groettrup, M. The unique functions of tissue-specific proteasomes. Trends Biochem. Sci. 2014, 39, 17-24.
77. Ethen, C.M.; Hussong, S.A.; Reilly, C.; Feng, X.; Olsen, T.W.; Ferrington, D.A. Transformation of the proteasome with age-related macular degeneration. FEBS Lett. 2007, 581, 885-890.
78. Pickering, A.M.; Koop, A.L.; Teoh, C.Y.; Ermak, G.; Grune, T.; Davies, K.J. The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem. J. 2010, 432, 585-594.
79. Seifert, U.; Bialy, L.P.; Ebstein, F.; Bech-Otschir, D.; Voigt, A.; Schroter, F.; Prozorovski, T.; Lange, N.; Steffen, J.; Rieger, M.; et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 2010, 142, 613-624.
80. Murata, S.; Sasaki, K.; Kishimoto, T.; Niwa, S.; Hayashi, H.; Takahama, Y.; Tanaka, K. Regulation of CD8+ T cell development by thymus-specific proteasomes. Science 2007, 316, 1349-1353.
81. Klein, L.; Hinterberger, M.; Wirnsberger, G.; Kyewski, B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat. Rev. Immunol. 2009, 9, 833-844.
82. Zhong, L.; Belote, J.M. The testis-specific proteasome subunit Prosalpha6T of D. Melanogaster is required for individualization and nuclear maturation during spermatogenesis. Development 2007, 134, 3517-3525.
83. Moscovitz, M.; Ben-Nissan, G.; Fainer, I.; Polack, D.; Mizrachi, L.; Sharon, M. Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel. Unpublished work, 2014.
84. Moscovitz, O.; Tsvetkov, P.; Hazan, N.; Michaelevski, I.; Keisar, H.; Ben-Nissan, G.; Shaul, Y.; Sharon, M. A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1. Mol. Cell 2012, 47, 76-86.
85. Patrick, B.A.; Jaiswal, A.K. Stress-induced NQO1 controls stability of C/EBPalpha against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer. Oncogene 2012, 31, 4362-4371.
86. Sollner, S.; Schober, M.; Wagner, A.; Prem, A.; Lorkova, L.; Palfey, B.A.; Groll, M.; Macheroux, P. Quinone reductase acts as a redox switch of the 20S yeast proteasome. EMBO Rep. 2009, 10, 65-70.
87. De Long, M.J.; Prochaska, H.J.; Talalay, P. Induction of NAD(P)H: Quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: A model system for the study of anticarcinogens. Proc. Natl. Acad. Sci. USA 1986, 83, 787-791.
88. Asher, G.; Dym, O.; Tsvetkov, P.; Adler, J.; Shaul, Y. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Biochemistry 2006, 45, 6372-6378.
89. Xu, J.; Patrick, B.A.; Jaiswal, A.K. NRH: Quinone oxidoreductase 2 (NQO2) protein competes with the 20S proteasome to stabilize transcription factor CCAAT enhancer-binding protein alpha (C/EBPalpha), leading to protection against gamma radiation-induced myeloproliferative disease. J. Biol. Chem. 2013, 288, 34799-34808.
90. Gong, X.; Kole, L.; Iskander, K.; Jaiswal, A.K. NRH: Quinone oxidoreductase 2 and NAD(P)H: Quinone oxidoreductase 1 protect tumor suppressor p53 against 20S proteasomal degradation leading to stabilization and activation of p53. Cancer Res. 2007, 67, 5380-5388.
91. Csermely, P.; Schnaider, T.; Soti, C.; Prohaszka, Z.; Nardai, G. The 90-kDa molecular chaperone family: Structure, function, and clinical applications. A comprehensive review. Pharmacol. Ther. 1998, 79, 129-168.
92. Daturpalli, S.; Waudby, C.A.; Meehan, S.; Jackson, S.E. Hsp90 inhibits alpha-synuclein aggregation by interacting with soluble oligomers. J. Mol. Biol. 2013, 425, 4614-4628.
93. Whittier, J.E.; Xiong, Y.; Rechsteiner, M.C.; Squier, T.C. Hsp90 enhances degradation of oxidized calmodulin by the 20S proteasome. J. Biol. Chem. 2004, 279, 46135-46142.
94. Eleuteri, A.M.; Cuccioloni, M.; Bellesi, J.; Lupidi, G.; Fioretti, E.; Angeletti, M. Interaction of Hsp90 with 20S proteasome: Thermodynamic and kinetic characterization. Proteins 2002, 48, 169-177.
95. Wagner, B.J.; Margolis, J.W. Age-dependent association of isolated bovine lens multicatalytic proteinase complex (proteasome) with heat-shock protein 90, an endogenous inhibitor. Arch. Biochem. Biophys. 1995, 323, 455-462.
96. Conconi, M.; Szweda, L.I.; Levine, R.L.; Stadtman, E.R.; Friguet, B. Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. Arch. Biochem. Biophys. 1996, 331, 232-240.
97. Conconi, M.; Petropoulos, I.; Emod, I.; Turlin, E.; Biville, F.; Friguet, B. Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90. Biochem. J. 1998, 333, 407-415.
98. Ullrich, O.; Reinheckel, T.; Sitte, N.; Hass, R.; Grune, T.; Davies, K.J. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl. Acad. Sci. USA 1999, 96, 6223-6228.
99. Catalgol, B.; Wendt, B.; Grimm, S.; Breusing, N.; Ozer, N.K.; Grune, T. Chromatin repair after oxidative stress: Role of PARP-mediated proteasome activation. Free Radic. Biol. Med. 2010, 48, 673-680.
100. Banasik, M.; Komura, H.; Shimoyama, M.; Ueda, K. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. J. Biol. Chem. 1992, 267, 1569-1575.
101. Mayer-Kuckuk, P.; Ullrich, O.; Ziegler, M.; Grune, T.; Schweiger, M. Functional interaction of poly(ADP-ribose) with the 20S proteasome in vitro. Biochem. Biophys. Res. Commun. 1999, 259, 576-581.
102. Bakondi, E.; Catalgol, B.; Bak, I.; Jung, T.; Bozaykut, P.; Bayramicli, M.; Ozer, N.K.; Grune, T. Age-related loss of stress-induced nuclear proteasome activation is due to low PARP-1 activity. Free Radic. Biol. Med. 2011, 50, 86-92.
103. Abbas, T.; Sivaprasad, U.; Terai, K.; Amador, V.; Pagano, M.; Dutta, A. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 2008, 22, 2496-2506.
104. Xu, H.; Zhang, Z.; Li, M.; Zhang, R. MDM2 promotes proteasomal degradation of p21WAF1 via a conformation change. J. Biol. Chem. 2010, 285, 18407-18414.
105. Jin, Y.; Lee, H.; Zeng, S.X.; Dai, M.S.; Lu, H. MDM2 promotes p21WAF1/CIP1 proteasomal turnover independently of ubiquitylation. EMBO J. 2003, 22, 6365-6377.
106. Zhang, Z.; Wang, H.; Li, M.; Agrawal, S.; Chen, X.; Zhang, R. MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J. Biol. Chem. 2004, 279, 16000-16006.
107. Touitou, R.; Richardson, J.; Bose, S.; Nakanishi, M.; Rivett, J.; Allday, M.J. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J. 2001, 20, 2367-2375.
108. Wang, B.; Liu, K.; Lin, H.Y.; Bellam, N.; Ling, S.; Lin, W.C. 14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. Mol. Cell. Biol. 2010, 30, 1508-1527.
109. Onel, K.; Cordon-Cardo, C. MDM2 and prognosis. Mol. Cancer Res. 2004, 2, 1-8.
110. Oeckinghaus, A.; Ghosh, S. The NF-κB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 2009, doi: 10.1101/cshperspect.a000034.
111. Petropoulos, L.; Hiscott, J. Association between HTLV-1 Tax and I kappa B alpha is dependent on the I kappa B alpha phosphorylation state. Virology 1998, 252, 189-199.
112. Rousset, R.; Desbois, C.; Bantignies, F.; Jalinot, P. Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature 1996, 381, 328-331.
113. Kehn, K.; Fuente Cde, L.; Strouss, K.; Berro, R.; Jiang, H.; Brady, J.; Mahieux, R.; Pumfery, A.; Bottazzi, M.E.; Kashanchi, F. The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene 2005, 24, 525-540.
114. Cui, Z.; Scruggs, S.B.; Gilda, J.E.; Ping, P.; Gomes, A.V. Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond. J. Mol. Cell. Cardiol. 2013, 71, 32-42.
115. Liu, X.; Huang, W.; Li, C.; Li, P.; Yuan, J.; Li, X.; Qiu, X.B.; Ma, Q.; Cao, C. Interaction between c-Abl and Arg tyrosine kinases and proteasome subunit PSMA7 regulates proteasome degradation. Mol. Cell 2006, 22, 317-327.
116. Feng, Y.; Longo, D.L.; Ferris, D.K. Polo-like kinase interacts with proteasomes and regulates their activity. Cell Growth Differ. 2001, 12, 29-37.
117. Day, S.M.; Divald, A.; Wang, P.; Davis, F.; Bartolone, S.; Jones, R.; Powell, S.R. Impaired assembly and post-translational regulation of 26S proteasome in human end-stage heart failure. Circ. Heart Fail. 2013, 6, 544-549.
118. Bose, S.; Stratford, F.L.; Broadfoot, K.I.; Mason, G.G.; Rivett, A.J. Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. Biochem. J. 2004, 378, 177-184.
119. Silva, G.M.; Netto, L.E.; Simoes, V.; Santos, L.F.; Gozzo, F.C.; Demasi, M.A.; Oliveira, C.L.; Bicev, R.N.; Klitzke, C.F.; Sogayar, M.C.; et al. Redox control of 20S proteasome gating. Antioxid. Redox Signal. 2012, 16, 1183-1194.
120. Demasi, M.; Silva, G.M.; Netto, L.E. 20S proteasome from saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J. Biol. Chem. 2003, 278, 679-685.
121. Silva, G.M.; Netto, L.E.; Discola, K.F.; Piassa-Filho, G.M.; Pimenta, D.C.; Barcena, J.A.; Demasi, M. Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl-based redox modification of the 20S proteasome. FEBS J. 2008, 275, 2942-2955.
122. De Sa, M.F.G.; de Sa, C.M.; Harper, F.; Olink-Coux, M.; Huesca, M.; Scherrer, K. The association of prosomes with some of the intermediate filament networks of the animal cell. J. Cell Biol. 1988, 107, 1517-1530.
123. Olink-Coux, M.; Arcangeletti, C.; Pinardi, F.; Minisini, R.; Huesca, M.; Chezzi, C.; Scherrer, K. Cytolocation of prosome antigens on intermediate filament subnetworks of cytokeratin, vimentin and desmin type. J. Cell Sci. 1994, 107, 353-366.
124. Brooks, P.; Murray, R.Z.; Mason, G.G.; Hendil, K.B.; Rivett, A.J. Association of immunoproteasomes with the endoplasmic reticulum. Biochem. J. 2000, 352, 611-615.
125. Wojcik, C.; DeMartino, G.N. Intracellular localization of proteasomes. Int. J. Biochem. Cell Biol. 2003, 35, 579-589.
126. Wigley, W.C.; Fabunmi, R.P.; Lee, M.G.; Marino, C.R.; Muallem, S.; DeMartino, G.N.; Thomas, P.J. Dynamic association of proteasomal machinery with the centrosome. J. Cell Biol. 1999, 145, 481-490.
127. Baldin, V.; Militello, M.; Thomas, Y.; Doucet, C.; Fic, W.; Boireau, S.; Jariel-Encontre, I.; Piechaczyk, M.; Bertrand, E.; Tazi, J.; et al. A novel role for PA28γ-proteasome in nuclear speckle organization and SR protein trafficking. Mol. Biol. Cell 2008, 19, 1706-1716.
128. Ogiso, Y.; Tomida, A.; Tsuruo, T. Nuclear localization of proteasomes participates in stress-inducible resistance of solid tumor cells to topoisomerase II-directed drugs. Cancer Res. 2002, 62, 5008-5012.
129. Blickwedehl, J.; McEvoy, S.; Wong, I.; Kousis, P.; Clements, J.; Elliott, R.; Cresswell, P.; Liang, P.; Bangia, N. Proteasomes and proteasome activator 200 kDa (PA200) accumulate on chromatin in response to ionizing radiation. Radiat. Res. 2007, 167, 663-674.
130. Yoshii, S.R.; Kishi, C.; Ishihara, N.; Mizushima, N. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J. Biol. Chem. 2011, 286, 19630-19640.
131. Bochmann, I.; Ebstein, F.; Lehmann, A.; Wohlschlaeger, J.; Sixt, S.U.; Kloetzel, P.M.; Dahlmann, B. T lymphocytes export proteasomes by way of microparticles: A possible mechanism for generation of extracellular proteasomes. J. Cell. Mol. Med. 2014, 18, 59-68.
132. Majetschak, M.; Perez, M.; Sorell, L.T.; Lam, J.; Maldonado, M.E.; Hoffman, R.W. Circulating 20S proteasome levels in patients with mixed connective tissue disease and systemic lupus erythematosus. Clin. Vaccine Immunol. 2008, 15, 1489-1493.
133. Majetschak, M.; Zedler, S.; Romero, J.; Albright, J.M.; Kraft, R.; Kovacs, E.J.; Faist, E.; Gamelli, R.L. Circulating proteasomes after burn injury. J. Burn Care Res. 2010, 31, 243-250.
134. Mueller, O.; Anlasik, T.; Wiedemann, J.; Thomassen, J.; Wohlschlaeger, J.; Hagel, V.; Keyvani, K.; Schwieger, I.; Dahlmann, B.; Sure, U.; et al. Circulating extracellular proteasome in the cerebrospinal fluid: A study on concentration and proteolytic activity. J. Mol. Neurosci. 2012, 46, 509-515.
135. Roth, G.A.; Moser, B.; Krenn, C.; Roth-Walter, F.; Hetz, H.; Richter, S.; Brunner, M.; Jensen-Jarolim, E.; Wolner, E.; Hoetzenecker, K.; et al. Heightened levels of circulating 20S proteasome in critically ill patients. Eur. J. Clin. Investig. 2005, 35, 399-403.
136. Sixt, S.U.; Dahlmann, B. Extracellular, circulating proteasomes and ubiquitin-incidence and relevance. Biochim. Biophys. Acta 2008, 1782, 817-823.
137. Alvarez-Castelao, B.; Goethals, M.; Vandekerckhove, J.; Castano, J.G. Mechanism of cleavage of alpha-synuclein by the 20S proteasome and modulation of its degradation by the redox state of the N-terminal methionines. Biochim. Biophys. Acta 2014, 1843, 352-365.
138. Tsvetkov, P.; Reuven, N.; Shaul, Y. The nanny model for IDPs. Nat. Chem. Biol. 2009, 5, 778-781.
139. Frankland-Searby, S.; Bhaumik, S.R. The 26S proteasome complex: An attractive target for cancer therapy. Biochim. Biophys. Acta 2012, 1825, 64-76.
140. Kisselev, A.F.; Goldberg, A.L. Proteasome inhibitors: From research tools to drug candidates. Chem. Biol. 2001, 8, 739-758.
141. Bross, P.F.; Kane, R.; Farrell, A.T.; Abraham, S.; Benson, K.; Brower, M.E.; Bradley, S.; Gobburu, J.V.; Goheer, A.; Lee, S.L.; et al. Approval summary for bortezomib for injection in the treatment of multiple myeloma. Clin. Cancer Res. 2004, 10, 3954-3964.
142. Stein, M.L.; Groll, M. Applied techniques for mining natural proteasome inhibitors. Biochim. Biophys. Acta 2014, 1843, 26-38.